Cargando…

Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy

BACKGROUND: Neurostimulation devices including vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation (RNS) are approved therapeutic options for drug resistant epilepsy (DRE). As these devices are increasingly used in clinical practice, it is of importance to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Arafat, Thaera, Miron, Gadi, Strauss, Ido, Fahoum, Firas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583742/
https://www.ncbi.nlm.nih.gov/pubmed/36276845
http://dx.doi.org/10.1016/j.ebr.2022.100566
_version_ 1784813135009415168
author Arafat, Thaera
Miron, Gadi
Strauss, Ido
Fahoum, Firas
author_facet Arafat, Thaera
Miron, Gadi
Strauss, Ido
Fahoum, Firas
author_sort Arafat, Thaera
collection PubMed
description BACKGROUND: Neurostimulation devices including vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation (RNS) are approved therapeutic options for drug resistant epilepsy (DRE). As these devices are increasingly used in clinical practice, it is of importance to recognize their artifacts in electrodiagnostic studies. METHODS: This is a retrospective study of all adult DRE patients treated with neuromodulation devices for epilepsy at our center between 2012 and 2021. Available EEGs were reviewed for neurostimulator-related artifacts. RESULTS: Fifty-two patients were included. 37% of patients had neurostimulation related electrophysiological artifacts (20% of VNS, 75% of DBS, all patients with dual VNS-DBS treatment, and in the single patient with RNS). Artifacts were intermittent, appearing most commonly simultaenously in the EEG and ECG. VNS artifacts were monomorphic appearing mostly in the lower temporal EEG electrodes, whereas DBS artifacts were with variable morphology, amplitude, and scalp distribution. At times, the artifacts resembled electrographic seizures in the EEG and mimicked extrasystole or asystole in the ECG. CONCLUSIONS: With the increasing use of neurostimulation treatments for DRE, and the need for frequent electrodiagnostic studies in this patient population, it is important clinicians recognize these electrophysiological findings as artifacts, to avoid misdiagnosis and facilitate accurate interpretation.
format Online
Article
Text
id pubmed-9583742
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95837422022-10-21 Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy Arafat, Thaera Miron, Gadi Strauss, Ido Fahoum, Firas Epilepsy Behav Rep Article BACKGROUND: Neurostimulation devices including vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation (RNS) are approved therapeutic options for drug resistant epilepsy (DRE). As these devices are increasingly used in clinical practice, it is of importance to recognize their artifacts in electrodiagnostic studies. METHODS: This is a retrospective study of all adult DRE patients treated with neuromodulation devices for epilepsy at our center between 2012 and 2021. Available EEGs were reviewed for neurostimulator-related artifacts. RESULTS: Fifty-two patients were included. 37% of patients had neurostimulation related electrophysiological artifacts (20% of VNS, 75% of DBS, all patients with dual VNS-DBS treatment, and in the single patient with RNS). Artifacts were intermittent, appearing most commonly simultaenously in the EEG and ECG. VNS artifacts were monomorphic appearing mostly in the lower temporal EEG electrodes, whereas DBS artifacts were with variable morphology, amplitude, and scalp distribution. At times, the artifacts resembled electrographic seizures in the EEG and mimicked extrasystole or asystole in the ECG. CONCLUSIONS: With the increasing use of neurostimulation treatments for DRE, and the need for frequent electrodiagnostic studies in this patient population, it is important clinicians recognize these electrophysiological findings as artifacts, to avoid misdiagnosis and facilitate accurate interpretation. Elsevier 2022-09-27 /pmc/articles/PMC9583742/ /pubmed/36276845 http://dx.doi.org/10.1016/j.ebr.2022.100566 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Arafat, Thaera
Miron, Gadi
Strauss, Ido
Fahoum, Firas
Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
title Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
title_full Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
title_fullStr Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
title_full_unstemmed Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
title_short Electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
title_sort electrodiagnostic artifacts due to neurostimulation devices for drug resistant epilepsy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583742/
https://www.ncbi.nlm.nih.gov/pubmed/36276845
http://dx.doi.org/10.1016/j.ebr.2022.100566
work_keys_str_mv AT arafatthaera electrodiagnosticartifactsduetoneurostimulationdevicesfordrugresistantepilepsy
AT mirongadi electrodiagnosticartifactsduetoneurostimulationdevicesfordrugresistantepilepsy
AT straussido electrodiagnosticartifactsduetoneurostimulationdevicesfordrugresistantepilepsy
AT fahoumfiras electrodiagnosticartifactsduetoneurostimulationdevicesfordrugresistantepilepsy